Webinar - Copay Accumulators, Maximizers, and Alternative Funding Programs: What’s at Stake for Patients?

Join NPC on Thursday, April 17 at 2:30 PM ET for a discussion on the rise of controversial "cost-shifting" programs.

WEBINAR: Copay Accumulators, Maximizers, and Alternative Funding Programs: What’s at Stake for Patients?

Patients have been raising concerns about the negative effects of copay accumulators, maximizers, and alternative funding programs. New research is shining more light on their harmful impact on patients' access to treatment, care experience, and health.

Join the National Pharmaceutical Council on Thursday, April 17, from 2:30 to 3:30 PM ET, for a discussion with researchers and patient leaders on the rise of these controversial "cost-shifting" programs, their effects on patients, and policy actions to curtail them. Audience Q&A will follow the panel discussion.

Kim Czubaruk, Associate Vice President of Policy CancerCare Carl Schmid, Executive Director,  HIV+Hepatitis Policy Institute

Kim Czubaruk

Associate Vice President of Policy 

CancerCare

 

Carl Schmid

Executive Director

HIV+Hepatitis Policy Institute

 

Kimberly Westrich, Chief Strategy Officer,  NPCJohn O’Brien, President & CEO,  NPC (moderator)

Kimberly Westrich

Chief Strategy Officer

NPC

John O’Brien

President & CEO

NPC (moderator)

 

Thanks to the HIV+Hepatitis Policy Institute and CancerCare for making this webinar possible.

 

Image
Webinar Icon

Register Now

After registering, you will receive a confirmation email containing information about joining the meeting via Zoom.

We hope you will join us for this important conversation.

Sign-Up for the Webinar